KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Other Operating Expenses (2016 - 2025)

Thermo Fisher Scientific's Other Operating Expenses history spans 17 years, with the latest figure at $7.2 billion for Q4 2025.

  • For the quarter ending Q4 2025, Other Operating Expenses rose 9.61% year-over-year to $7.2 billion, compared with a TTM value of $26.3 billion through Dec 2025, up 4.54%, and an annual FY2025 reading of $26.3 billion, up 3.18% over the prior year.
  • Other Operating Expenses for Q4 2025 was $7.2 billion at Thermo Fisher Scientific, up from $6.5 billion in the prior quarter.
  • The five-year high for Other Operating Expenses was $7.2 billion in Q4 2025, with the low at $4.7 billion in Q4 2021.
  • Average Other Operating Expenses over 5 years is $6.1 billion, with a median of $6.4 billion recorded in 2022.
  • Year-over-year, Other Operating Expenses soared 36.25% in 2022 and then dropped 6.56% in 2024.
  • Tracing TMO's Other Operating Expenses over 5 years: stood at $5.4 billion in 2021, then grew by 25.62% to $6.8 billion in 2022, then decreased by 5.13% to $6.5 billion in 2023, then rose by 1.25% to $6.6 billion in 2024, then rose by 9.61% to $7.2 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Other Operating Expenses are $7.2 billion (Q4 2025), $6.5 billion (Q3 2025), and $6.4 billion (Q2 2025).